Prorenoate potassium

Chemical structure of Prorenoate Potassium

Prorenoate potassium is a pharmaceutical drug that acts as a mineralocorticoid receptor antagonist. It is primarily used in the treatment of conditions such as hypertension and heart failure. This compound is a potassium salt form of prorenoic acid, which enhances its solubility and bioavailability.

Mechanism of Action

Prorenoate potassium works by blocking the action of aldosterone, a hormone that increases the reabsorption of sodium and water in the kidneys. By inhibiting aldosterone, prorenoate potassium promotes the excretion of sodium and water, thereby reducing blood volume and lowering blood pressure. This mechanism is particularly beneficial in patients with conditions like congestive heart failure where fluid retention is a significant concern.

Clinical Uses

Prorenoate potassium is used in the management of:

• Hypertension: As an adjunct therapy to control high blood pressure.
• Heart failure: To reduce symptoms and improve survival in patients with heart failure.
• Edema: Associated with conditions like cirrhosis and nephrotic syndrome.

Side Effects

Common side effects of prorenoate potassium include:

• Hyperkalemia: Elevated levels of potassium in the blood, which can be dangerous.
• Dizziness: Due to lowered blood pressure.
• Gastrointestinal disturbances: Such as nausea and vomiting.

Pharmacokinetics

Prorenoate potassium is well absorbed from the gastrointestinal tract. It is metabolized in the liver and excreted primarily in the urine. The drug has a half-life that allows for once or twice daily dosing, depending on the clinical scenario.

Related Pages

• Mineralocorticoid receptor antagonist
• Aldosterone
• Hypertension
• Heart failure